HCT Stock Overview
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Holista Colltech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.024 |
| 52 Week High | AU$0.027 |
| 52 Week Low | AU$0.004 |
| Beta | 0.078 |
| 11 Month Change | 9.09% |
| 3 Month Change | 380.00% |
| 1 Year Change | 140.00% |
| 33 Year Change | -58.62% |
| 5 Year Change | -68.83% |
| Change since IPO | -81.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| HCT | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 4.3% | 2.7% | 0.2% |
| 1Y | 140.0% | 85.1% | 15.9% |
Return vs Industry: HCT exceeded the Australian Personal Products industry which returned 85.1% over the past year.
Return vs Market: HCT exceeded the Australian Market which returned 15.9% over the past year.
Price Volatility
| HCT volatility | |
|---|---|
| HCT Average Weekly Movement | 32.9% |
| Personal Products Industry Average Movement | 13.3% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: HCT's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine HCT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.holistaco.com |
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Food Ingredients, and Infection Control Solutions segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.
Holista Colltech Limited Fundamentals Summary
| HCT fundamental statistics | |
|---|---|
| Market cap | AU$6.69m |
| Earnings (TTM) | -AU$4.64m |
| Revenue (TTM) | AU$5.46m |
1.2x
P/S Ratio-1.4x
P/E RatioIs HCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HCT income statement (TTM) | |
|---|---|
| Revenue | AU$5.46m |
| Cost of Revenue | AU$3.20m |
| Gross Profit | AU$2.26m |
| Other Expenses | AU$6.89m |
| Earnings | -AU$4.64m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 41.33% |
| Net Profit Margin | -84.97% |
| Debt/Equity Ratio | -35.9% |
How did HCT perform over the long term?
See historical performance and comparison